SCHEMBL5755558

SCHEMBL5755558

CC(C)NC(=O)c1ccc2[nH]c(-c3cc[nH]n3)cc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.48
ROCK2 O75116 3/20 0.45
RIPK1 Q13546 1/20 0.45
B3GNT2 Q9NY97 1/20 0.41
IKBKB O14920 4/20 0.41
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
ITK Q08881 1/20 0.40
CYP17A1 P05093 1/20 0.39
CYP3A4 P08684 1/20 0.39
PRKD1 Q15139 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5754383 0.90 ROCK2 (0.52) ROCK2RIPK1TAS1R3TAS1R1ITK
SCHEMBL5759216 0.88 ITK (0.51) HDAC6RIPK1IKBKBITK
SCHEMBL5754329 0.86 KMT2A (0.45) HDAC6IKBKBTAS1R3TAS1R1ITK
SCHEMBL5755542 0.84 RIPK1 (0.44) HDAC6ROCK2RIPK1IKBKBITK
SCHEMBL6480600 0.84 CHEK1 (0.43) HDAC6KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5756790 0.82 RIPK1 (0.46) HDAC6RIPK1ITKCYP17A1CYP3A4
SCHEMBL5754444 0.82 HRH3 (0.46) HDAC6ITKKDM4EALDH1A1HPGD
SCHEMBL5757088 0.81 RAB9A (0.48) RIPK1KDM4EALDH1A1HPGDHPGDS
SCHEMBL6486561 0.81 ITK (0.41) HDAC6IKBKBITKKDM4EALDH1A1
SCHEMBL5752904 0.81 ITK (0.55) HDAC6ITKKDM4EALDH1A1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP disclosed
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 HDAC6 739/4885ROCK2 600/4885RIPK1 404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.